Research.Patient.info
Systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) research hub
2 indexed studies · 0 currently recruiting
- ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging, Parallel and Adaptive Study to Evaluate the Efficacy and Safety of Enpatoran in Systemic Lupus Erythematosus and in Cutaneous Lupus Erythematosus (Subacute Cutaneous Lupus Erythematosus and/or Discoid Lupus Erythematosus) Participants Receiving Standard of Care
This study is testing a new medicine called Enpatoran for people with lupus that affects their whole body or their skin. Researchers want to see if it's safe and helps improve symptoms compared to a dummy drug, and find the best dose.
Spain · Greece · Romania - ongoing, recruitingHuman Pharmacology (Phase I)- Other
Effect of Renal Impairment on Enpatoran Pharmacokinetics
This study looks at how a new medicine, Enpatoran, moves through the body in people with kidney problems compared to healthy volunteers. It's an early-stage study to understand how kidney function might affect the medicine, which is being developed for conditions like lupus.
Germany